A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder.

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

The largest and most diverse genetic study of depression has identified 300 new genetic risk factors for the condition across ...

The highest-risk items that could be lurking in your medicine cabinet include aspirin, which can degrade over time because of ...

Why men are using ketamine to treat their depression - Elon Musk is a fan of it, Matthew Perry attempted it before he died.

Healthcare professionals may recommend tapering off antidepressants, like Lexapro, if you experience unwanted side effects, need to switch medications, or have reached the end of a short-term ...

This paper reviews recent findings on the pharmacogenetics of antidepressant drugs and future clinical applications. Ultimately, these studies should lead to the use of genetic testing to guide ...